Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension

Completed · Phase 4

Conditions studied: Hypertension

In brief

To evaluate the effects of two different antihypertensive medications in the drug class of beta-blockers on control of glucose in Type II diabetic patients with high blood pressure.

Key facts

Study ID

NCT00060918

Run by

GlaxoSmithKline

People needed

1210

Starts

2001-06-01

Expected to finish

2004-04-01

Last updated by the study team

2015-04-15

Who can join

Age: 30 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients at screening must be insulin producing Type II diabetics (C peptide positive).
• Must have a history of mild to moderate hypertension (140-179 systolic; 90-1-9 diastolic).
• Must be on stable regimen of ACE (angiotensin converting enzyme) / ARB (angiotensin receptor blocker) treatment alone or in combination with other treatments.
• Patient''s laboratory result for HbA1c must be 6.5 - 8.5 (drug treated) or 6.5 - 7.5 (diet alone).
• Must be on a stable antidiabetic regimen (drug treated or diet alone).

You may not qualify if…

• Patients using beta-blocker therapy.

Where it is running

• GSK Investigational Site — Glendale, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Tucson, Arizona, United States
• GSK Investigational Site — Burlingame, California, United States
• GSK Investigational Site — Concord, California, United States
• GSK Investigational Site — Encinitas, California, United States
• GSK Investigational Site — Hemet, California, United States
• GSK Investigational Site — Long Beach, California, United States
• GSK Investigational Site — Orange, California, United States
• GSK Investigational Site — Pasadena, California, United States
• GSK Investigational Site — Riverside, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — San Luis Obispo, California, United States
• GSK Investigational Site — Spring Valley, California, United States
• GSK Investigational Site — Aurora, Colorado, United States
• GSK Investigational Site — Denver, Colorado, United States
• GSK Investigational Site — Golden, Colorado, United States
• GSK Investigational Site — Panama City, Florida, United States
• GSK Investigational Site — St. Petersburg, Florida, United States
• GSK Investigational Site — Honolulu, Hawaii, United States
• GSK Investigational Site — Idaho Falls, Idaho, United States
• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — O'Fallon, Illinois, United States
• GSK Investigational Site — Elkhart, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.